{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-239559","form_type":"8-K","ticker":"VERA","cik":"0001831828","company_name":"Vera Therapeutics, Inc.","filed_at":"2026-05-26T20:54:31+00:00","discovered_at":"2026-05-26T20:55:07.403813+00:00","generated_at":"2026-05-26T20:57:22.086453+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"confidence":"high","headline":"Vera Therapeutics stockholders elect three Class II directors, ratify KPMG, approve say-on-pay","bullets":["Michael M. Morrisey elected with 45.3M For, 13.8M Withheld; Patrick G. Enright with 54.7M For; James R. Meyers with 58.9M For.","Ratification of KPMG as auditor for FY 2026 approved (61.8M For, 44.7K Against, 87.3K Abstain).","Advisory vote on executive compensation approved (56.6M For, 2.4M Against, 84.3K Abstain, 2.9M Broker non-votes).","71.7M shares outstanding and entitled to vote as of record date March 24, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-239559","json":"https://secwatch.observer/filing/0001193125-26-239559.json","markdown":"https://secwatch.observer/filing/0001193125-26-239559.md","text":"https://secwatch.observer/filing/0001193125-26-239559.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831828/000119312526239559/0001193125-26-239559-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831828/000119312526239559/vera-20260521.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T20:57:22.086453+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}